Highlights and Quick Summary
- Current Ratio for the quarter ending September 30, 2022 was 6.37 (a -21.78% decrease compared to previous quarter)
- Year-over-year quarterly Current Ratio decreased by -12.07%
- Annual Current Ratio for 2021 was 7.24 (a -49.37% decrease from previous year)
- Annual Current Ratio for 2020 was 14.3 (a -35.46% decrease from previous year)
- Annual Current Ratio for 2019 was 22.16 (a -13.75% decrease from previous year)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Current Ratio of Atreca, Inc.
Most recent Current Ratioof BCEL including historical data for past 10 years.Interactive Chart of Current Ratio of Atreca, Inc.
Atreca, Inc. Current Ratio for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | 6.37 | 8.14 | 9.57 | – |
2021 | 7.24 | 10.03 | 13.48 | 11.99 | 7.24 |
2020 | 14.3 | 28.48 | 20.21 | 22.49 | 14.3 |
2019 | – | 22.16 | 27.38 | 26.46 | 22.16 |
2018 | – | – | – | 25.7 | 25.7 |
2017 | – | – | – | – | 11.66 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology